Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results

Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results

Background: Sarpogrelate is a selective 5-hydroxytryptamine (5-HT) receptor subtype 2A antagonist which blocks 5-HT induced platelet aggregation and proliferation of vascular smooth muscle cells. We compared the efficacy of sarpogrelate-based dual antiplatelet therapies for the prevention of resteno...

Full description

Bibliographic Details
Main Authors: Yue-Xin Chen, Wen-Da Wang, Xiao-Jun Song, Yong-Quan Gu, Hong-Yan Tian, He-Jie Hu, Ji-Chun Zhao, Xiao-Qiang Li, Chang-Wei Liu
Format: Article
Language:English
Published: Wolters Kluwer 2015-01-01
Series:Chinese Medical Journal
Subjects:
Clopidogrel; Femoropopliteal Artery; Percutaneous Endovascular Interventions; Restenosis; Sarpogrelate
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=12;spage=1563;epage=1566;aulast=Chen

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=12;spage=1563;epage=1566;aulast=Chen

Similar Items